Skip to main content
. 2022 Apr 23;11(1):2067944. doi: 10.1080/2162402X.2022.2067944

Figure 2.

Figure 2.

Quantitative analysis of plasma-circulating sEVs from patients included in the study according to their central nervous system (CNS) metastases status (including healthy/cured controls). a. Particles/ml in lung cancer. b. Particles/ml in breast cancer. c. Particles/ml in kidney cancer. d. Particles/ml in melanoma. e. Proteins/ml in lung cancer. f. Proteins/ml in breast cancer. g. Proteins/ml in kidney cancer. h. Proteins/ml in melanoma. * p value < .05. ** p value < .01. ^ p value < .05. ^^ p value 0.003. ^^^ p value 0.0003. ns: not significant.